|
Q4 2021
Filed on Feb 14, 2022
|
149,493
|
$11.8 - $14.35
$1.76M - $2.15M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
86,400
|
$3.49 - $5.23
$302K - $452K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
234,211
|
N/A
|
|
Altimar Acquisition Corp Ii
|
Q4 2021
Filed on Feb 14, 2022
|
50,000
|
N/A
|
|
Altimar Acquisition Corp Ii
|
Q4 2021
Filed on Feb 14, 2022
|
12,500
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
250,000
|
$1.11 - $1.86
$278K - $465K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
93,960
|
$4.19 - $13.97
$394K - $1.31M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
50,000
|
$10.73 - $19.47
$537K - $974K
|
|
Ccc Intelligent Solutions Hl
|
Q4 2021
Filed on Feb 14, 2022
|
260,000
|
N/A
|
|
Cerberus Telecom Acquisition
|
Q4 2021
Filed on Feb 14, 2022
|
20,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
60,000
|
$20.54 - $34.43
$1.23M - $2.07M
|
|
European Sustainable Growth
|
Q4 2021
Filed on Feb 14, 2022
|
12,500
|
N/A
|
|
European Sustainable Growth
|
Q4 2021
Filed on Feb 14, 2022
|
25,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
8,700
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
250,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
1,967,200
|
$7.51 - $15.9
$14.8M - $31.3M
|
|
Kensington Capital Acquisiti
|
Q4 2021
Filed on Feb 14, 2022
|
25,000
|
N/A
|
|
Kensington Capital Acquisiti
|
Q4 2021
Filed on Feb 14, 2022
|
50,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
1,087,113
|
$5.87 - $8.01
$6.38M - $8.71M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
44,900
|
$2.04 - $3.65
$91.6K - $164K
|
|
Reinvent Technology Partners
|
Q4 2021
Filed on Feb 14, 2022
|
70,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
40,000
|
$19.38 - $26.91
$775K - $1.08M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
47,500
|
$30.08 - $39.69
$1.43M - $1.89M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
8,500
|
$84.54 - $113.02
$719K - $961K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
100,400
|
$2.21 - $3.22
$222K - $323K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
200,000
|
$15.98 - $25.5
$3.2M - $5.1M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
500,000
|
$4.89 - $10.7
$2.45M - $5.35M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
50,000
|
$43.83 - $63.66
$2.19M - $3.18M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
100,000
|
$26.27 - $46.85
$2.63M - $4.69M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
50,000
|
$18.38 - $40.5
$919K - $2.03M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
500,000
|
$7.51 - $15.9
$3.76M - $7.95M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
600,000
|
$6.87 - $11.32
$4.12M - $6.79M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
500,000
|
$3.79 - $6.61
$1.9M - $3.31M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
150,000
|
$41.79 - $55.61
$6.27M - $8.34M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
524,400
|
$71.88 - $114.85
$37.7M - $60.2M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
75,000
|
$30.74 - $49.16
$2.31M - $3.69M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
400,000
|
$60.25 - $67.16
$24.1M - $26.9M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
201,147
|
$10.94 - $14.17
$2.2M - $2.85M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
162,094
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
53,318
|
$94.85 - $145.19
$5.06M - $7.74M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
493,382
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
154,800
|
$18.94 - $26.99
$2.93M - $4.18M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
898,282
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
283,475
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
201,900
|
$65.73 - $72.17
$13.3M - $14.6M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
469,765
|
$6.03 - $7.95
$2.83M - $3.73M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
184,506
|
$146.49 - $189.88
$27M - $35M
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
172,583
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
831,595
|
N/A
|
|
Pieris Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 15, 2021
|
1,000,000
|
N/A
|
|